DMD - dystrophin Gene
Species: Felis catus
Gene Type: protein coding
Gene ID: 101084937
DMD Products (40)
| mRNA | Protein | Name |
|---|---|---|
| XM_045050793.1 | XP_044906728.1 | dystrophin isoform X7 |
| XM_045050788.1 | XP_044906723.1 | dystrophin isoform X2 |
| XM_045050791.1 | XP_044906726.1 | dystrophin isoform X5 |
| XM_045050792.1 | XP_044906727.1 | dystrophin isoform X6 |
| XM_045050789.1 | XP_044906724.1 | dystrophin isoform X3 |
| XM_045050787.1 | XP_044906722.1 | dystrophin isoform X1 |
| XM_045050790.1 | XP_044906725.1 | dystrophin isoform X4 |
| XM_045050794.1 | XP_044906729.1 | dystrophin isoform X8 |
| XM_045050797.1 | XP_044906732.1 | dystrophin isoform X10 |
| XM_045050795.1 | XP_044906730.1 | dystrophin isoform X9 |
| XM_045050796.1 | XP_044906731.1 | dystrophin isoform X10 |
| XM_045050798.1 | XP_044906733.1 | dystrophin isoform X11 |
| XM_045050799.1 | XP_044906734.1 | dystrophin isoform X12 |
| XM_045050801.1 | XP_044906736.1 | dystrophin isoform X13 |
| XM_045050802.1 | XP_044906737.1 | dystrophin isoform X14 |
| XM_045050803.1 | XP_044906738.1 | dystrophin isoform X15 |
| XM_045050807.1 | XP_044906742.1 | dystrophin isoform X19 |
| XM_045050804.1 | XP_044906739.1 | dystrophin isoform X16 |
| XM_045050806.1 | XP_044906741.1 | dystrophin isoform X18 |
| XM_045050805.1 | XP_044906740.1 | dystrophin isoform X17 |
| XM_045050793.1 | XP_044906728.1 | dystrophin isoform X7 |
| XM_045050788.1 | XP_044906723.1 | dystrophin isoform X2 |
| XM_045050791.1 | XP_044906726.1 | dystrophin isoform X5 |
| XM_045050792.1 | XP_044906727.1 | dystrophin isoform X6 |
| XM_045050789.1 | XP_044906724.1 | dystrophin isoform X3 |
| XM_045050787.1 | XP_044906722.1 | dystrophin isoform X1 |
| XM_045050790.1 | XP_044906725.1 | dystrophin isoform X4 |
| XM_045050794.1 | XP_044906729.1 | dystrophin isoform X8 |
| XM_045050797.1 | XP_044906732.1 | dystrophin isoform X10 |
| XM_045050795.1 | XP_044906730.1 | dystrophin isoform X9 |
| XM_045050796.1 | XP_044906731.1 | dystrophin isoform X10 |
| XM_045050798.1 | XP_044906733.1 | dystrophin isoform X11 |
| XM_045050799.1 | XP_044906734.1 | dystrophin isoform X12 |
| XM_045050801.1 | XP_044906736.1 | dystrophin isoform X13 |
| XM_045050802.1 | XP_044906737.1 | dystrophin isoform X14 |
| XM_045050803.1 | XP_044906738.1 | dystrophin isoform X15 |
| XM_045050807.1 | XP_044906742.1 | dystrophin isoform X19 |
| XM_045050804.1 | XP_044906739.1 | dystrophin isoform X16 |
| XM_045050806.1 | XP_044906741.1 | dystrophin isoform X18 |
| XM_045050805.1 | XP_044906740.1 | dystrophin isoform X17 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
dystrophin |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(5)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-14842 | Givinostat | Inhibitor | 98.67% | Yes |
| HY-132611 | Golodirsen | 96.12% | Unkown | |
| HY-132611A | Golodirsen sodium | Modulator | 92.00% | Unkown |
| HY-132584A | Casimersen sodium | 98.50% | Unkown | |
| HY-132584 | Casimersen | 92.50% | Unkown |
Clinical Phase
Bioactive Molecules
(6)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-132586A | Viltolarsen sodium | Modulator | 95.25% | Phase 4 |
| HY-132586 | Viltolarsen | Modulator | 95.25% | Phase 4 |
| HY-108753 | Eteplirsen | 98.50% | Phase 3 | |
| HY-134377 | Bocidelpar | Modulator | 98.08% | Phase 2 |
| HY-17614 | Ezutromid | 98.87% | Phase 2 | |
| HY-127137 | Adenylosuccinic acid | 99.74% | Phase 1 |
Inhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-P99857 | Domagrozumab | Inhibitor | 96.34% | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(20)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-152182 | ML-SA5 | Agonist | 99.69% | Unkown |
| HY-147332 | TCL053 | 99.97% | Unkown | |
| HY-15898 | Y-320 | 99.03% | Unkown | |
| HY-101459 | RTC13 | 98.01% | Unkown | |
| HY-122631 | TG693 | 99.95% | Unkown | |
| HY-127137A | Adenylosuccinic acid tetraammonium | 99.62% | Unkown | |
| HY-139972 | PROTAC(H-PGDS)-7 | 99.42% | Unkown | |
| HY-114739 | MA-0204 | Modulator | 99.31% | Unkown |
| HY-153369 | BAY-747 | Activator | 98.01% | Unkown |
| HY-122588A | Negamycin hydrochloride | 80.0% | Unkown | |
| HY-150237 | FITC-labeled Drisapersen sodium | Inhibitor | 92.99% | Unkown |
| HY-RS03823 | DMD Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-147253 | Brogidirsen | / | Unkown | |
| HY-14931 | Naproxcinod | Inhibitor | / | Unkown |
| HY-150077 | Utrophin modulator 1 | / | Unkown | |
| HY-150078 | OX01914 | / | Unkown | |
| HY-177659 | Rimigorsen | Inhibitor | / | Unkown |
| HY-177659A | Rimigorsen sodium | Inhibitor | / | Unkown |
| HY-RS18019 | Dmd Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS24492 | Dmd Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Inhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P990051 | Delpacibart | 98.06% | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service